Drug intelligence / Profile preview

fluorescein isothiocyanate

Development stage
Unknown
Lead developer
Robert Seiwald and Joseph Burckhalter
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01

Overview

Fluorescein isothiocyanate (FITC) is a synthetic organic compound and a derivative of fluorescein functionalized with an amine-reactive isothiocyanate group (−N=C=S). It emits bright green fluorescence when excited by blue light (excitation peak ~495 nm; emission peak ~519–520 nm)[2][4][8]. FITC covalently binds to primary amines on proteins and other biomolecules via its reactive isothiocyanate group to form stable thiourea bonds. This property makes it widely used as a fluorescent labeling reagent in biochemistry and molecular biology for applications such as flow cytometry, immunofluorescence microscopy, immunoassays (ELISA), fluorescence in situ hybridization (FISH), protein detection in gels/Western blots, and cell tracking. FITC can be supplied as either of two positional isomers—fluorescein 5-isothiocyanate or fluorescein 6-isothiocyanate—or as a mixture. Its main limitation compared to newer dyes like Alexa Fluor or DyLight series is photobleaching susceptibility[2][4]. FITC itself does not have therapeutic effects; it serves exclusively as a diagnostic/research tool.

Other names
fluorescein isothiocyanate isomer Ifluorescein-5-isothiocyanatefluorescein5-isothiocyanatefluorescein 5-isothiocyanateSpiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-5-isothiocyanato-2-(6-hydroxy-3-oxo-(3H)-xanthene-9-yl)-5-isothiocyanato benzoic acid

Beyond the preview

Go deeper on fluorescein isothiocyanate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluorescein isothiocyanate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call